XML 137 R137.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value of Financial Instruments Summary of Estimated Fair Values of Investments and Remaining Unfunded Commitments for Each Major Category of Investments (Textual) (Detail) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Fair Value $ 1,132,070
Unfunded Commitments 478,920
Non-marketable securities | Fair value accounting | Venture capital and private equity fund investments
 
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Fair Value 862,972 [1]
Unfunded Commitments 428,139 [1]
Non-marketable securities | Equity method accounting | Other investments
 
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Fair Value 54,544 [2]
Unfunded Commitments 15,436 [2]
Non-marketable securities | Cost method accounting | Venture capital and private equity fund investments
 
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Fair Value 214,554 [3]
Unfunded Commitments 35,345 [3]
Non-marketable securities | Noncontrolling Interests | Fair value accounting | Venture capital and private equity fund investments
 
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Fair Value 786,000
Unfunded Commitments $ 422,000
Non-marketable securities | Lower Limit | Fair value accounting | Venture capital and private equity fund investments
 
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Estimated future period of distributions from the fund investments 10 years
Non-marketable securities | Lower Limit | Equity method accounting | Other investments
 
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Estimated future period of distributions from the fund investments 10 years
Non-marketable securities | Lower Limit | Cost method accounting | Venture capital and private equity fund investments
 
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Estimated future period of distributions from the fund investments 10 years
Non-marketable securities | Upper Limit | Fair value accounting | Venture capital and private equity fund investments
 
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Estimated future period of distributions from the fund investments 13 years
Non-marketable securities | Upper Limit | Equity method accounting | Other investments
 
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Estimated future period of distributions from the fund investments 13 years
Non-marketable securities | Upper Limit | Cost method accounting | Venture capital and private equity fund investments
 
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]  
Estimated future period of distributions from the fund investments 13 years
[1] Venture capital and private equity fund investments within non-marketable and other securities (fair value accounting) include investments made by our managed funds of funds and one of our direct venture funds. These investments represent investments in venture capital and private equity funds that invest primarily in U.S. and global technology and life sciences companies. Included in the fair value and unfunded commitments of fund investments under fair value accounting are $786 million and $422 million, respectively, attributable to noncontrolling interests. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of terms of the funds.
[2] Other investments within non-marketable securities (equity method accounting) include investments in debt funds and venture capital and private equity fund investments that invest in or lend money to primarily U.S. and global technology and life sciences companies. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds.
[3] Venture capital and private equity fund investments within non-marketable securities (cost method accounting) include investments in venture capital and private equity fund investments that invest primarily in U.S. and global technology and life sciences companies. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of the terms of the funds.